Seeing Is Believing

Currently out of the existing stock ratings of Joseph Schwartz, 270 are a BUY (82.07%), 55 are a HOLD (16.72%), 4 are a SELL (1.22%).
Analyst Joseph Schwartz, carries an average stock price target met ratio of 61.79% that have a potential upside of 44.57% achieved within 390 days. Previously, Joseph Schwartz worked at LEERINK.
Joseph Schwartz’s has documented 650 price targets and ratings displayed on 58 stocks. The coverage was on Healthcare, Energy, Financial Services sectors.
Most recent stock forecast was given on QURE, Uniqure NV at 18-Jun-2026.
Analyst best performing recommendations are on LRMR (LARIMAR THERAPEUTICS).
The best stock recommendation documented was for LRMR (LARIMAR THERAPEUTICS) at 12/1/2015. The price target of $132 was fulfilled within 1 day with a profit of $59.16 (30.95%) receiving and performance score of 309.48.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 05-Oct-2020
$13.75
$14
5 years 9 months 24 days ago
(05-Oct-2020)
10/15 (66.67%)
$0.67 (5.12%)
51
Hold Since 02-Oct-2020
$13.75
$14
5 years 9 months 27 days ago
(02-Oct-2020)
4/7 (57.14%)
$0.01 (0.07%)
109
Hold Since 12-Jun-2015
$10
5 years 11 months 10 days ago
(19-Aug-2020)
7/10 (70%)
$-0.63 (-5.93%)
139
Hold Since 18-Aug-2020
$10
$-3.75 (-27.27%)
$20
5 years 11 months 11 days ago
(18-Aug-2020)
1/4 (25%)
$-0.63 (-5.93%)
6
Hold Since 21-May-2018
$10
$-3.75 (-27.27%)
5 years 11 months 22 days ago
(07-Aug-2020)
1/3 (33.33%)
$-0.55 (-5.21%)
17
Which stock is Joseph Schwartz is most bullish on?
Which stock is Joseph Schwartz is most reserved on?
What Year was the first public recommendation made by Joseph Schwartz?